Physician profile
Gary J Keepes
NPI 1104829480
$477.89
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $137.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $63.41 | 2019-2020 | |
| Lilly USA, LLC | $55.69 | 2019-2020 | |
| Allergan, INC. | $43.73 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.36 | 2019-2020 | |
| Mylan Specialty L.P. | $38.48 | 2019-2020 | |
| Amgen INC. | $35.36 | 2019 | |
| Glaxosmithkline, LLC. | $31.55 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $27.75 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $27.56 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $14.73 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.42 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.38 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.30 | 2019 | |
| Shire North American Group INC | $12.13 | 2019 | |
| Pfizer INC. | $11.99 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11.57 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.39 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Keepes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.